{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:10Z","timestamp":1791308830229,"version":"4.3.1"},"reference-count":35,"publisher":"American Association for Cancer Research (AACR)","issue":"16","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2006,8,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Although androgen deprivation therapy is a widely used treatment for patients with advanced prostate cancer, it ultimately results in the emergence of a hormone-refractory disease that is invariably fatal. To provide insights into the genesis of this disease, we have employed an in vivo model to investigate how and when prostate epithelial cells can acquire the ability to survive and proliferate in the absence of androgens. In particular, we have been studying the evolution of androgen independence in Nkx3.1; Pten mutant mice, which develop prostatic intraepithelial neoplasia and adenocarcinoma as a consequence of aging, as well as androgen-independent phenotypes following castration. We now find that the prostate epithelial cells from these Nkx3.1; Pten mutant mice are capable of surviving and proliferating in the absence of androgens and that they develop androgen-independent phenotypes well before they display overt prostatic intraepithelial neoplasia or cancer phenotypes. Our findings in this mouse model show that acquisition of androgen independence can be uncoupled from overt cancer progression and raise the possibility that hormone-refractory disease can arise at early stages of prostate carcinogenesis. (Cancer Res 2006; 66(16): 7929-33)<\/jats:p>","DOI":"10.1158\/0008-5472.can-06-1637","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T13:20:57Z","timestamp":1155648057000},"page":"7929-7933","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Emergence of Androgen Independence at Early Stages of Prostate Cancer Progression in\n                    <i>Nkx3.1; Pten<\/i>\n                    Mice"],"prefix":"10.1158","volume":"66","author":[{"given":"Hui","family":"Gao","sequence":"first","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"2The Cancer Institute of New Jersey, and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesong","family":"Ouyang","sequence":"additional","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"2The Cancer Institute of New Jersey, and Departments of"},{"name":"3Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney A.","family":"Banach-Petrosky","sequence":"additional","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Shen","sequence":"additional","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"2The Cancer Institute of New Jersey, and Departments of"},{"name":"4Pediatrics, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Piscataway, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cory","family":"Abate-Shen","sequence":"additional","affiliation":[{"name":"1Center for Advanced Biotechnology and Medicine,"},{"name":"2The Cancer Institute of New Jersey, and Departments of"},{"name":"3Medicine and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"key":"2022061622123991500_B1","doi-asserted-by":"crossref","unstructured":"Cunha GR, Donjacour AA, Cooke PS, et al. The endocrinology and developmental biology of the prostate. Endocr Rev\u20081987; 8: 338\u201362.","DOI":"10.1210\/edrv-8-3-338"},{"key":"2022061622123991500_B2","doi-asserted-by":"crossref","unstructured":"Debes JD, Tindall DJ. Mechanisms of androgen-refractory prostate cancer. N Engl J Med\u20082004; 351: 1488\u201390.","DOI":"10.1056\/NEJMp048178"},{"key":"2022061622123991500_B3","doi-asserted-by":"crossref","unstructured":"Feldman BJ, Feldman D. The development of androgen-independent prostate cancer. Nat Rev Cancer\u20082001; 1: 34\u201345.","DOI":"10.1038\/35094009"},{"key":"2022061622123991500_B4","doi-asserted-by":"crossref","unstructured":"Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr\u20082000; 27: 39\u201366.","DOI":"10.1093\/oxfordjournals.jncimonographs.a024244"},{"key":"2022061622123991500_B5","doi-asserted-by":"crossref","unstructured":"Heinlein CA, Chang C. Androgen receptor in prostate cancer. Endocr Rev\u20082004; 25: 276\u2013308.","DOI":"10.1210\/er.2002-0032"},{"key":"2022061622123991500_B6","doi-asserted-by":"crossref","unstructured":"Buchanan G, Irvine RA, Coetzee GA, Tilley WD. Contribution of the androgen receptor to prostate cancer predisposition and progression. Cancer Metastasis Rev\u20082001; 20: 207\u201323.","DOI":"10.1023\/A:1015531326689"},{"key":"2022061622123991500_B7","doi-asserted-by":"crossref","unstructured":"Taplin ME, Balk SP. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem\u20082004; 91: 483\u201390.","DOI":"10.1002\/jcb.10653"},{"key":"2022061622123991500_B8","unstructured":"Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev\u20082001; 20: 173\u201393."},{"key":"2022061622123991500_B9","doi-asserted-by":"crossref","unstructured":"Shen MM, Abate-Shen C. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn\u20082003; 228: 767\u201378.","DOI":"10.1002\/dvdy.10397"},{"key":"2022061622123991500_B10","doi-asserted-by":"crossref","unstructured":"Abdulkadir SA, Magee JA, Peters TJ, et al. Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol\u20082002; 22: 1495\u2013503.","DOI":"10.1128\/MCB.22.5.1495-1503.2002"},{"key":"2022061622123991500_B11","doi-asserted-by":"crossref","unstructured":"Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, et al. Roles for Nkx3.1 in prostate development and cancer. Genes Dev\u20081999; 13: 966\u201377.","DOI":"10.1101\/gad.13.8.966"},{"key":"2022061622123991500_B12","doi-asserted-by":"crossref","unstructured":"Ellwood-Yen K, Graeber TG, Wongvipat J, et al. Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell\u20082003; 4: 223\u201338.","DOI":"10.1016\/S1535-6108(03)00197-1"},{"key":"2022061622123991500_B13","unstructured":"Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, et al. Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res\u20082002; 62: 2999\u20133004."},{"key":"2022061622123991500_B14","unstructured":"Voeller HJ, Augustus M, Madike V, Bova GS, Carter KC, Gelmann EP. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Cancer Res\u20081997; 57: 4455\u20139."},{"key":"2022061622123991500_B15","doi-asserted-by":"crossref","unstructured":"Wang S, Gao J, Lei Q, et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell\u20082003; 4: 209\u201321.","DOI":"10.1016\/S1535-6108(03)00215-0"},{"key":"2022061622123991500_B16","unstructured":"Bowen C, Bubendorf L, Voeller HJ, et al. Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res\u20082000; 60: 6111\u20135."},{"key":"2022061622123991500_B17","doi-asserted-by":"crossref","unstructured":"Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell\u20082000; 100: 387\u201390.","DOI":"10.1016\/S0092-8674(00)80674-1"},{"key":"2022061622123991500_B18","doi-asserted-by":"crossref","unstructured":"Paez J, Sellers WR. PI3K\/PTEN\/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res\u20082003; 115: 145\u201367.","DOI":"10.1007\/0-306-48158-8_6"},{"key":"2022061622123991500_B19","doi-asserted-by":"crossref","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer\u20082002; 2: 489\u2013501.","DOI":"10.1038\/nrc839"},{"key":"2022061622123991500_B20","unstructured":"McMenamin ME, Soung P, Perera S, Kaplan I, Loda M, Sellers WR. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res\u20081999; 59: 4291\u20136."},{"key":"2022061622123991500_B21","doi-asserted-by":"crossref","unstructured":"Whang YE, Wu X, Suzuki H, et al. Inactivation of the tumor suppressor PTEN\/MMAC1 in advanced human prostate cancer through loss of expression. Proc Natl Acad Sci U S A\u20081998; 95: 5246\u201350.","DOI":"10.1073\/pnas.95.9.5246"},{"key":"2022061622123991500_B22","unstructured":"Abate-Shen C, Banach-Petrosky WA, Sun X, et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res\u20082003; 63: 3886\u201390."},{"key":"2022061622123991500_B23","doi-asserted-by":"crossref","unstructured":"Chen Z, Trotman LC, Shaffer D, et al. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature\u20082005; 436: 725\u201330.","DOI":"10.1038\/nature03918"},{"key":"2022061622123991500_B24","doi-asserted-by":"crossref","unstructured":"Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet\u20082001; 27: 222\u20134.","DOI":"10.1038\/84879"},{"key":"2022061622123991500_B25","doi-asserted-by":"crossref","unstructured":"Kim MJ, Cardiff RD, Desai N, et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A\u20082002; 99: 2884\u20139.","DOI":"10.1073\/pnas.042688999"},{"key":"2022061622123991500_B26","doi-asserted-by":"crossref","unstructured":"Hsing AW, Reichardt JK, Stanczyk FZ. Hormones and prostate cancer: current perspectives and future directions. Prostate\u20082002; 52: 213\u201335.","DOI":"10.1002\/pros.10108"},{"key":"2022061622123991500_B27","doi-asserted-by":"crossref","unstructured":"Park JH, Walls JE, Galvez JJ, et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol\u20082002; 161: 727\u201335.","DOI":"10.1016\/S0002-9440(10)64228-9"},{"key":"2022061622123991500_B28","doi-asserted-by":"crossref","unstructured":"Mizokami A, Koh E, Fujita H, et al. The adrenal androgen androstenediol is present in prostate cancer tissue after androgen deprivation therapy and activates mutated androgen receptor. Cancer Res\u20082004; 64: 765\u201371.","DOI":"10.1158\/0008-5472.CAN-03-0130"},{"key":"2022061622123991500_B29","doi-asserted-by":"crossref","unstructured":"Bertram J, Peacock JW, Fazli L, et al. Loss of PTEN is associated with progression to androgen independence. Prostate\u20082006; 66: 895\u2013902.","DOI":"10.1002\/pros.20411"},{"key":"2022061622123991500_B30","doi-asserted-by":"crossref","unstructured":"Wu Z, Conaway M, Gioeli D, Weber MJ, Theodorescu D. Conditional expression of PTEN alters the androgen responsiveness of prostate cancer cells. Prostate\u20082006; 66: 1114\u201323.","DOI":"10.1002\/pros.20447"},{"key":"2022061622123991500_B31","unstructured":"Craft N, Chhor C, Tran C, et al. Evidence for clonal outgrowth of androgen-independent prostate cancer cells from androgen-dependent tumors through a two-step process. Cancer Res\u20081999; 59: 5030\u20136."},{"key":"2022061622123991500_B32","unstructured":"Isaacs JT, Coffey DS. Adaptation versus selection as the mechanism responsible for the relapse of prostatic cancer to androgen ablation therapy as studied in the Dunning R-3327-H adenocarcinoma. Cancer Res\u20081981; 41: 5070\u20135."},{"key":"2022061622123991500_B33","doi-asserted-by":"crossref","unstructured":"Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med\u20082003; 349: 215\u201324.","DOI":"10.1056\/NEJMoa030660"},{"key":"2022061622123991500_B34","doi-asserted-by":"crossref","unstructured":"Rubin MA, Kantoff PW. Effect of finasteride on risk of prostate cancer: how little we really know. J Cell Biochem\u20082004; 91: 478\u201382.","DOI":"10.1002\/jcb.10787"},{"key":"2022061622123991500_B35","doi-asserted-by":"crossref","unstructured":"Scardino PT. The prevention of prostate cancer\u2014the dilemma continues. N Engl J Med\u20082003; 349: 297\u20139.","DOI":"10.1056\/NEJMe038109"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/16\/7929\/2552169\/7929.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/66\/16\/7929\/2552169\/7929.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T20:17:37Z","timestamp":1655410657000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/66\/16\/7929\/525997\/Emergence-of-Androgen-Independence-at-Early-Stages"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":35,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2006,8,15]]},"published-print":{"date-parts":[[2006,8,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-06-1637","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22364189","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22364189.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6494060","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6494060.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,15]]}}}